We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Valirx Plc | LSE:VAL | London | Ordinary Share | GB00BLH13C52 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.30 | 3.20 | 3.40 | 3.30 | 3.30 | 3.30 | 56,258 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Medical Laboratories | 0 | -2.37M | -0.0262 | -1.26 | 2.98M |
Date | Subject | Author | Discuss |
---|---|---|---|
22/9/2022 15:38 | Sums porky up Believing every word of Jason !!Porky you are the laughing stock of Aim V v sad | nico115 | |
22/9/2022 15:07 | He has confirmed you are talking total bo##cks. | teamhanz69 | |
22/9/2022 14:47 | If that were true @jp and Adam was saying that the THX situation was fantastic and they were releasing an RNS before the zoom then it would be insider information. Shareholders position prejudiced by not having the same information to make an informed decision as another key shareholder. He really should be made an official NED and abide by director dealing rules if this is the situation. | porky9 | |
22/9/2022 13:36 | Ask adam for confirmation buddy. And report back what you find. Teamhanz. Aka porky the deramper👍 | jasonpugh | |
22/9/2022 13:33 | Oh come on Pugh pants. We all know you talk absolute codswallop! | teamhanz69 | |
22/9/2022 13:30 | Adam Hargreaves also told me that suzy will release rns on theoromrx progress on 201 before zoom call. Says everything looking fantastic. 🚀🚀 | jasonpugh | |
22/9/2022 13:23 | Jasonpugh is that fact or your opinion? | pinkpudycat | |
22/9/2022 13:08 | Mark white. Biggest holder in bluestar capital has sold a chunk and hes buying into valirx. Tr1 expect..🚀 | jasonpugh | |
22/9/2022 08:58 | You said the same thing at 10p loser. | nico115 | |
22/9/2022 08:50 | I sense another update before zoom call date | baldrick1 | |
22/9/2022 08:29 | Franco. Do you require my assistance to help you understand what an rns means. Would be a pleasure to help | jasonpugh | |
22/9/2022 08:27 | Should collect today - 15p looks nailed on today | francoismyname | |
22/9/2022 07:51 | All the ducks are lined up now. | 412069 | |
22/9/2022 07:39 | Suzy just tweeted 5 mins ago. See suzy dily on twitter. What do you notice about her comments? The way she says YES stands out. Boom 💥. Nick slater just tweeted aswell. He thinks 201 confirmation of secured funds for 201. Double BOOM🚀㉀ | jasonpugh | |
22/9/2022 07:35 | Rns dated 30th june 2022 on extension of exclusivity period for Theoremrx on 201 funding. Its states on para 3 “A further update will be made in due course” If Theoremrx couldnt get funds then we would have been told already via official rns! Conclusion. Theoremrx will get funds and everything on course. Director buys. Options. Cenkos incentive Looking good 👍🚀 | jasonpugh | |
22/9/2022 07:10 | You would have thought something big coming in next seven days? | sweepie2 | |
22/9/2022 07:07 | Yes. Just read rns base. You are very correct. Looking extremely good 🚀🚀 | jasonpugh | |
21/9/2022 23:52 | Perhaps he has gone 'inside'& therefore unable to comment ,for now? | base7 | |
21/9/2022 18:39 | Where has adam Hargreaves gone on lse site? Mysteriously vanished | jasonpugh | |
21/9/2022 16:30 | Trap door opening wide into the close. Going to be painful tomorrow morning. | francoismyname | |
21/9/2022 15:47 | It may retrace but it will bounce double quick! | wulber | |
21/9/2022 15:45 | Leave it off Francois! | wulber | |
21/9/2022 15:44 | Timber !!!!!!!! | francoismyname | |
21/9/2022 15:38 | Last minute buying as predicted gla | baldrick1 | |
21/9/2022 14:52 | Bulk of the shares in sticky hands..soon mms will come begging for ithem. | baldrick1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions